You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

November 17, 2020

Practical Law Life Sciences Global Guide: Pharmaceutical IP and Competition Law in Thailand (November 2020)

Subscribe to Updates
Thomson Reuters Practical Law

The Thailand updates to Practical Law’s Life Sciences Global Guide  have been released online, with legal practitioners from Tilleke & Gibbins contributing the Pharmaceutical Intellectual Property and Competition Law section.

The guide is a Q&A-style overview of the regulatory frameworks of the life sciences industries across multiple jurisdictions worldwide, with this chapter addressing the following issues as they relate to Thailand:

  • Pharmaceutical patent legislation and scope of protection
  • Patent application process, duration of protection, and revocation
  • Patent infringement, claims, and remedies
  • Non-patent barriers to competition for pharmaceutical protection
  • Pharmaceutical trademark legislation and scope of protection
  • Trademark application process, duration of protection, and revocation
  • Trademark infringement, claims, and remedies
  • Regulatory powers and enforcement against pharmaceutical counterfeiting
  • Competition law framework and implications for the pharmaceutical sector
  • Competition issues related to licensing of pharmaceutical technology and patents, and market entry of generic products
  • Market dominance issues in the pharmaceutical sector
  • Parallel imports
  • Foreign patent and trademark licenses, and payment of royalties

The full Pharmaceutical Intellectual Property and Competition Law in Thailand chapter can be accessed on the Practical Law website.

Practical Law, produced by Thomson Reuters, is the world’s leading legal know-how resource for business lawyers, publishing a huge range of guides covering hundreds of jurisdictions and practice areas. Tilleke & Gibbins also drafted an updated chapter on Medicinal Product Regulation and Product Liability in Thailand, which Practical Law has published in its Life Sciences Global Guide  at the same time.

Related Professionals

Industries

Life Sciences

Practices

Intellectual Property

Regulatory Affairs

Location

RELATED INSIGHTS​ 

February 25, 2020
The Thailand updates of Thomson Reuters’ Practical Law Life Sciences Global Guide  have been released online, with legal practitioners from Tilleke & Gibbins contributing the Pharmaceutical Intellectual Property and Competition Law section.The guide is a Q&A-style overview of the regulatory frameworks of the life sciences industries across multiple jurisdictions worldwide, with this chapter addressing the following issues as they relate to Thailand:
Read More
February 5, 2020
Southeast Asian food exporters to China should be aware of new regulations announced in late November 2019 by China’s General Administration of Customs (GAC) for all food products. The first is still in draft form and seeks to expand the scope of the GAC’s role in policing all food products, while the second update—already implemented–makes the application process for an import license for animal and plant food products much more rigorous.
Read More
January 28, 2020
Tilleke & Gibbins authors have provided the latest update to the Thailand Q&A section of Doing Business in… , a Q&A-style guide published by Thomson Reuters Practical Law that presents an overview of recent legal developments affecting doing business in 59 jurisdictions worldwide. The Thailand chapter of the guide was written by attorneys from Tilleke & Gibbins and presents an overview of Thailand’s legal system and key laws applicable to foreign companies doing business in the country.
Read More
January 6, 2020
On December 13, 2019, the Vietnamese government issued Decree No. 94/2019/ND-CP (Decree 94) providing detailed guidance on some articles of the Law on Crop Production related to plant varieties and cultivation. Decree 94 will come into effect on February 1, 2020.Notably, Decree 94 includes a list of plant variety genetic resources banned from export. In addition, it provides detailed regulations on labeling, conditions for trading or manufacturing, and administrative procedures related to plant varieties to facilitate the manufacture, trade or import of plant varieties.
Read More